Neuroendocrine cell hyperplasia of infancy
ICD-10 J84.841 is a billable code used to indicate a diagnosis of neuroendocrine cell hyperplasia of infancy.
Neuroendocrine cell hyperplasia of infancy (NEHI) is a rare lung condition characterized by an abnormal proliferation of neuroendocrine cells in the lungs of infants. Clinically, it presents with respiratory distress, recurrent wheezing, and chronic cough, often leading to significant breathing difficulties. The condition primarily affects the small airways, resulting in obstructive lung disease. The pathophysiology involves hyperplasia of neuroendocrine cells, which may disrupt normal lung function and contribute to airway hyperreactivity. Diagnosis typically involves a combination of clinical evaluation, imaging studies such as chest X-rays or CT scans, and sometimes lung biopsy to confirm the presence of neuroendocrine cell hyperplasia. Disease progression can vary, with some infants experiencing spontaneous resolution, while others may develop chronic respiratory issues. Early identification and management are crucial to improving outcomes, as the condition can lead to long-term respiratory complications if left untreated.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J84.841 specifically covers neuroendocrine cell hyperplasia of infancy, which is characterized by the proliferation of neuroendocrine cells in the lungs, leading to respiratory symptoms in infants.
J84.841 should be used when there is a confirmed diagnosis of neuroendocrine cell hyperplasia of infancy, particularly when distinguishing from other interstitial lung diseases or respiratory conditions in infants.
Documentation should include clinical findings, imaging results, and any biopsy reports that confirm neuroendocrine cell hyperplasia. Detailed notes on the patient's respiratory symptoms and treatment response are also essential.
